Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

LUNG Pulmonx Corporation

6,08

-0,31 (-4,85%)

Última atualização: 17:48:55

Atrasado em 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

01/31/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

06/07/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Derrick Sung

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Pulmonx (NASDAQ:LUNG)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024

Click aqui para mais gráficos Pulmonx.

Pulmonx (NASDAQ:LUNG)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024

Click aqui para mais gráficos Pulmonx.

Notícias Pulmonx Corporation

Form 4 - Statement of changes in beneficial ownership of securities
Quarta, 4 de Dezembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Quarta, 4 de Dezembro de 2024 (1 semana atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Terça, 26 de Novembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Sexta, 22 de Novembro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
Quarta, 20 de Novembro de 2024 (3 semanas atrás) • GlobeNewswire Inc.

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
Terça, 19 de Novembro de 2024 (3 semanas atrás) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Quinta, 14 de Novembro de 2024 (4 semanas atrás) • Edgar (US Regulatory)

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Quinta, 7 de Novembro de 2024 (1 mês atrás) • GlobeNewswire Inc.

Pulmonx to Present at the Stifel 2024 Healthcare Conference
Terça, 5 de Novembro de 2024 (1 mês atrás) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sexta, 1 de Novembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Form 8-K - Current report
Quarta, 30 de Outubro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Pulmonx Reports Third Quarter 2024 Financial Results
Quarta, 30 de Outubro de 2024 (1 mês atrás) • GlobeNewswire Inc.

Mais Notícias de Pulmonx Corporation

Índice Bovespa

MAGAZINE LUIZA ON

Grupo Casas Bahia ON

Aeris Industria E Comerc... ON

Ambipar Participacoes e ... ON

TRIUNFO PART ON

Fundo Invest Amazonia Fi...

PÃO DE AÇUCAR ON

LOJAS RENNER ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições